Literature DB >> 23566103

Mutations in PRRT2 are not a common cause of infantile epileptic encephalopathies.

Sarah E Heron1, Yeh Sze Ong, Simone C Yendle, Jacinta M McMahon, Samuel F Berkovic, Ingrid E Scheffer, Leanne M Dibbens.   

Abstract

Heterozygous mutations in PRRT2 have recently been identified as the major cause of autosomal dominant benign familial infantile epilepsy (BFIE), infantile convulsions with choreoathetosis syndrome (ICCA), and paroxysmal kinesigenic dyskinesia (PKD). Homozygous mutations in PRRT2 have also been reported in two families with intellectual disability (ID) and seizures. Heterozygous mutations in the genes KCNQ2 and SCN2A cause the two other autosomal dominant seizure disorders of infancy: benign familial neonatal epilepsy and benign familial neonatal-infantile epilepsy. Mutations in KCNQ2 and SCN2A also contribute to severe infantile epileptic encephalopathies (IEEs) in which seizures and intellectual disability co-occur. We therefore hypothesized that PRRT2 mutations may also underlie cases of IEE. We examined PRRT2 for heterozygous, compound heterozygous or homozygous mutations to determine their frequency in causing epileptic encephalopathies (EEs). Two hundred twenty patients with EEs with onset by 2 years were phenotyped. An assay for the common PRRT2 c.649-650insC mutation and high resolution-melt analysis for mutations in the remaining exons of PRRT2 were performed. Neither the common mutation nor any other pathogenic variants in PRRT2 were detected in the 220 patients. Our findings suggest that mutations in PRRT2 are not a common cause of IEEs. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23566103     DOI: 10.1111/epi.12167

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Genetic biomarkers in epilepsy.

Authors:  Yvonne G Weber; Anne T Nies; Matthias Schwab; Holger Lerche
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

2.  Re-evaluation of PRRT2 mutations in paroxysmal disorders.

Authors:  Xia Nan Guo; Qiang Lu; Xiang Qin Zhou; Qing Liu; Xue Zhang; Li-Ying Cui
Journal:  J Neurol       Date:  2014-03-09       Impact factor: 4.849

Review 3.  Episodic movement disorders: from phenotype to genotype and back.

Authors:  Knut Brockmann
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

4.  PRRT2 mutations are related to febrile seizures in epileptic patients.

Authors:  Zheng-Wen He; Jian Qu; Ying Zhang; Chen-Xue Mao; Zhi-Bin Wang; Xiao-Yuan Mao; Zhi-Yong Deng; Bo-Ting Zhou; Ji-Ye Yin; Hong-Yu Long; Bo Xiao; Yu Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Int J Mol Sci       Date:  2014-12-16       Impact factor: 5.923

Review 5.  IFITMs restrict the replication of multiple pathogenic viruses.

Authors:  Jill M Perreira; Christopher R Chin; Eric M Feeley; Abraham L Brass
Journal:  J Mol Biol       Date:  2013-09-25       Impact factor: 5.469

6.  Novel Locus for Paroxysmal Kinesigenic Dyskinesia Mapped to Chromosome 3q28-29.

Authors:  Ding Liu; Yumiao Zhang; Yu Wang; Chanjuan Chen; Xin Li; Jinxia Zhou; Zhi Song; Bo Xiao; Kevin Rasco; Feng Zhang; Shu Wen; Guoliang Li
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

7.  A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.

Authors:  Anna Lauritano; Sebastien Moutton; Elena Longobardi; Frédéric Tran Mau-Them; Giusy Laudati; Piera Nappi; Maria Virginia Soldovieri; Paolo Ambrosino; Mauro Cataldi; Thibaud Jouan; Daphné Lehalle; Hélène Maurey; Christophe Philippe; Francesco Miceli; Antonio Vitobello; Maurizio Taglialatela
Journal:  Epilepsia Open       Date:  2019-08-11

Review 8.  Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction.

Authors:  Giulia Spoto; Giulia Valentini; Maria Concetta Saia; Ambra Butera; Greta Amore; Vincenzo Salpietro; Antonio Gennaro Nicotera; Gabriella Di Rosa
Journal:  Front Neurol       Date:  2022-03-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.